Coloplast A/S (OTCMKTS:CLPBY) Reaches New 52-Week Low – Here’s What Happened

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) reached a new 52-week low during mid-day trading on Monday . The stock traded as low as $5.86 and last traded at $5.93, with a volume of 3026 shares. The stock had previously closed at $6.00.

Analyst Ratings Changes

A number of brokerages have weighed in on CLPBY. The Goldman Sachs Group lowered Coloplast A/S from a “hold” rating to a “strong sell” rating in a report on Tuesday, April 7th. Kepler Capital Markets upgraded Coloplast A/S to a “strong-buy” rating in a research note on Wednesday, May 20th. One research analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold”.

Coloplast A/S Stock Down 0.7%

The company has a debt-to-equity ratio of 1.50, a current ratio of 1.30 and a quick ratio of 0.81. The company has a market capitalization of $13.43 billion, a price-to-earnings ratio of 42.57, a price-to-earnings-growth ratio of 1.90 and a beta of 0.18. The firm’s 50-day simple moving average is $6.46 and its two-hundred day simple moving average is $7.59.

Coloplast A/S (OTCMKTS:CLPBY) last released its quarterly earnings results on Tuesday, May 12th. The company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01. Coloplast A/S had a return on equity of 31.96% and a net margin of 7.46%.The business had revenue of $1.11 billion for the quarter, compared to analysts’ expectations of $1.11 billion. Sell-side analysts predict that Coloplast A/S Sponsored ADR will post 0.4 EPS for the current fiscal year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.